On September 22, 2025, Invivyd, Inc. appointed Dr. Paul B. Bolno as a director and to the Compensation Committee, following the resignation of Christine Akinc, who left the board for undisclosed reasons. Additionally, the company regained compliance with Nasdaq's minimum bid price requirements, having maintained a stock price of at least $1.00 per share for the necessary period.